Aries Biotech Partners with NeuroTheranostics, Inc.

Peptide-based Strategies for Healing Neurological Damage

Aries Biotech and NeuroTheranostics are merging their collective expertise in research and development to address potential impact of synthetic, protease-targeting compounds upon the central nervous system. These strategies have the potential to mitigate a broad spectrum of injuries and diseases.

To learn how we can assist with your needs within science and medicine, visit Aries Biotech at

19 views0 comments

Recent Posts

See All

Aries Biotech is pleased to announce new hours of operation! Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommod

Biomarkers for Neurological Disease and Dementia Aries Biotech and Neurovations are merging their expertise in research and development to measure biomarkers of dementia. Additional information for N